1. Home
  2. NRDS vs TBPH Comparison

NRDS vs TBPH Comparison

Compare NRDS & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRDS
  • TBPH
  • Stock Information
  • Founded
  • NRDS 2009
  • TBPH 2013
  • Country
  • NRDS United States
  • TBPH United States
  • Employees
  • NRDS N/A
  • TBPH N/A
  • Industry
  • NRDS EDP Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRDS Technology
  • TBPH Health Care
  • Exchange
  • NRDS Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • NRDS 785.4M
  • TBPH 699.0M
  • IPO Year
  • NRDS 2021
  • TBPH N/A
  • Fundamental
  • Price
  • NRDS $11.06
  • TBPH $14.40
  • Analyst Decision
  • NRDS Buy
  • TBPH Strong Buy
  • Analyst Count
  • NRDS 5
  • TBPH 4
  • Target Price
  • NRDS $13.80
  • TBPH $23.00
  • AVG Volume (30 Days)
  • NRDS 471.5K
  • TBPH 543.4K
  • Earning Date
  • NRDS 10-28-2025
  • TBPH 11-11-2025
  • Dividend Yield
  • NRDS N/A
  • TBPH N/A
  • EPS Growth
  • NRDS N/A
  • TBPH N/A
  • EPS
  • NRDS 0.60
  • TBPH 0.26
  • Revenue
  • NRDS $771,200,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • NRDS $16.46
  • TBPH $79.82
  • Revenue Next Year
  • NRDS $7.88
  • TBPH N/A
  • P/E Ratio
  • NRDS $18.48
  • TBPH $55.89
  • Revenue Growth
  • NRDS 28.75
  • TBPH 24.49
  • 52 Week Low
  • NRDS $7.55
  • TBPH $7.88
  • 52 Week High
  • NRDS $16.45
  • TBPH $14.55
  • Technical
  • Relative Strength Index (RSI)
  • NRDS 57.91
  • TBPH 72.80
  • Support Level
  • NRDS $10.32
  • TBPH $13.47
  • Resistance Level
  • NRDS $11.22
  • TBPH $14.42
  • Average True Range (ATR)
  • NRDS 0.33
  • TBPH 0.41
  • MACD
  • NRDS 0.07
  • TBPH -0.05
  • Stochastic Oscillator
  • NRDS 78.17
  • TBPH 86.11

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: